Wondering if you can still file a Zantac lawsuit in 2026?
Yes they can. But the playing field has changed dramatically in the last couple years. Thousands of Zantac users who were diagnosed with cancer are still filing claims in State Courts nationwide.
Here’s the deal:
The Zantac lawsuit comprises one of the biggest pharmaceutical mass torts in recent history. Pharmaceutical giants have already settled billions of dollars in claims, but thousands of lawsuits continue to make their way through the courts.
This guide breaks down the complete story of where things stand right now…
In this guide:
- How The Zantac Lawsuit Started
- Where The Zantac Lawsuit Stands Today
- Who Qualifies To File A Zantac Claim
- What Cancer Types Are Linked To Zantac
- What Settlement Payouts Look Like
Time to jump in!
How The Zantac Lawsuit Started
The Zantac litigation began in 2019 when an independent testing laboratory discovered an alarming contaminant in Zantac.
That something?
NDMA — a chemical the FDA classifies as a probable human carcinogen.
Scientists discovered ranitidine (the medicine in Zantac) can degrade into NDMA over time and when heated. This became a massive problem because Zantac was one of the leading heartburn medications for years. Stay informed with the latest Zantac lawsuit updates for 2026 information on state court decisions, settlements, and new filings.
In April 2020, the FDA issued a request to all manufacturers that they voluntarily recall ranitidine products.
This kicked off the floodgates…
The lawsuits began to pile up. Many of them. Users who took Zantac for years and then developed cancer sought justice. They claimed pharmaceutical companies knew (or should’ve known) about the NDMA dangers — but said nothing.
The drug received FDA approval in 1983. It rapidly became a worldwide blockbuster and was marketed at various times by:
- GlaxoSmithKline (GSK)
- Pfizer
- Sanofi
- Boehringer Ingelheim
Each of these companies is now named in thousands of lawsuits.
Where The Zantac Lawsuit Stands Today
The current Zantac lawsuit status is… complicated.
The multidistrict litigation (MDL) based in Florida was dismissed in 2022. The judge ruled that plaintiffs’ scientific proof of ranitidine causing cancer was unreliable. Plaintiffs suffered a significant setback as a result.
But here’s the kicker:
State courts breathed life into the litigation. Delaware, California, and Illinois continued to see activity. And toward the end of 2024, a seismic shift occurred.
GSK reached a deal to pay as much as $2.2 billion to settle 80,000 Zantac lawsuits. The agreement covers 93% of the state court lawsuits still pending against the company. It is one of the largest drugmaker settlements in history.
Pretty massive, right?
However, that was not the conclusion of the story. Pfizer and Sanofi each entered into settlements that involved thousands of additional claims. Meanwhile, Boehringer Ingelheim continues to fight.
A quick recap of the recent action:
- October 2024: GSK announces $2.2 billion settlement
- July 2025: Delaware Supreme Court rules against plaintiffs on expert testimony
- December 2025: Delaware court grants summary judgment in massive batch of cases
- 2026: State court trials continue in multiple jurisdictions
The Delaware ruling was particularly difficult on plaintiffs. In April 2026, a Delaware state court issued a ruling that dismissed more than 80,000 lawsuits filed against Boehringer Ingelheim in the state, effectively ending Zantac litigation there.
But cases are still very much active in other states.
Who Qualifies To File A Zantac Claim
If You Took Zantac, You May Not Be Able to Join a Lawsuit. Learn about eligibility.
Here’s what most lawyers look for:
- Regular use of Zantac or generic ranitidine
- Use that spanned at least one year (typically between 1983 and 2020)
- A cancer diagnosis after using the medication
- Medical records that document both the usage and the diagnosis
The best cases generally involve individuals who took prescription only Zantac (not OTC), took the drug for decades, and were diagnosed with a cancer that has a more proven connection to NDMA exposure.
Every state has their own statute of limitations — or time limit for filing a claim. Some states allow two years from date of diagnosis. Others allow four years. If you miss the deadline, you lose your right to sue forever.
That’s why moving fast matters so much.
What Cancer Types Are Linked To Zantac
No universal determination applies. Courts typically limit their awards to cancers that have the most scientifically credible connection to NDMA exposure.
The cancers most commonly linked to Zantac include:
- Stomach cancer
- Bladder cancer
- Pancreatic cancer
- Esophageal cancer
- Liver cancer
- Kidney cancer
- Prostate cancer
- Breast cancer
Bladder and stomach cancers show the strongest connection to NDMA scientifically. This makes sense – Zantac treated heartburn by acting in the stomach, so the highest exposure matches with highest risk.
Having a different cancer does not necessarily bar you from recovery. However, you may have a more difficult case if you lack concrete evidence connecting that cancer to NDMA.
What Settlement Payouts Look Like
How Much Money Could You Get From A Zantac Lawsuit?
The honest answer? It depends.
Damages range from several hundred thousand dollars to a million or more depending on cancer type, duration of Zantac use, age of diagnosis, medical bills and lost income.
Settlement amounts have generally fallen into three tiers:
- Tier 1 (most severe): Stomach, pancreatic, prostate — $300,000 to $500,000
- Tier 2 (moderate): Liver, bladder, kidney — $80,000 to $250,000
- Tier 3 (lower): Other cancers or non-cancer injuries — $20,000 to $75,000
These figures are estimates of what has already settled. They are not guaranteed.
Some plaintiffs have received more. Others have received less.
The factors that affect settlement amounts the most are:
- Strength of medical evidence
- Length of Zantac use
- Severity of injury
- Quality of legal representation
- Which state the case is filed in
Bringing It All Together
The Zantac lawsuit story isn’t over — not even close.
Sure the federal MDL was dismissed. Sure Delaware’s whopping bucket of cases got thrown out. But there are plenty of state court actions ongoing in California, Illinois, Connecticut etc. Trials are proceeding. New Zantac claims are still being filed.
If you took Zantac and have been diagnosed with cancer, you may still have a claim. However, time is of the essence. Statute of limitations are expiring.
The key takeaways:
- Major settlements have already happened, including GSK’s $2.2 billion deal
- State courts remain the active battleground
- Eligibility depends on usage history and cancer type
- Settlement amounts vary based on multiple factors
- Time limits apply in every state
The Zantac litigation demonstrates how large pharmaceutical litigation can take years (sometimes decades) to completely play out. Some plaintiffs have already received awards. Many plaintiffs have yet to see their day in court.
But one thing is clear — this litigation is far from finished.